Bexarotene 75 mg/1 (Bexarotene CAPSULE, LIQUID FILLED) 75 mg/1

Bexarotene 75 mg/1 is a medication used to treat certain skin conditions. This liquid-filled capsule is designed for oral administration and is manufactured by Mylan Pharmaceuticals Inc. in the USA.

Strength

75 mg/1

Pack Size

100 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (0378-6955-01)

Manufacturer / TM Owner

Mylan Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bexarotene 75 mg/1 is primarily used for the treatment of cutaneous T-cell lymphoma, a type of skin cancer. It works by targeting specific receptors in the body to help manage the symptoms associated with this condition. Patients often wonder, 'What is Bexarotene used for?' and the answer lies in its ability to address specific skin-related issues.

Side Effects

Common effects of Bexarotene 75 mg/1 may include skin-related changes such as dryness, itching, or rash. Some users might also experience gastrointestinal discomfort. These effects can vary from person to person and are not exhaustive.

Precautions & Warnings

When handling Bexarotene 75 mg/1, it is important to follow the prescribed guidelines. Store the medication as directed and avoid exposure to extreme temperatures. Always consult a healthcare provider before starting any new medication.

Avoid Interactions

Bexarotene 75 mg/1 may interact with certain medications, including those that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect how this medication works.

Frequently Asked Questions

Bexarotene is primarily used to treat cutaneous T-cell lymphoma, a type of skin cancer.

Bexarotene 75 mg/1 is taken orally, typically as directed by a healthcare provider.

Common side effects may include skin dryness, itching, rash, and gastrointestinal discomfort.

It is advisable to consult your healthcare provider before consuming alcohol while taking Bexarotene.

Store Bexarotene 75 mg/1 as directed, typically at room temperature and away from moisture and heat.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.